This is a firm fixed-price delivery order awarded by the Veterinary Services agency to Illumina, Inc., a leading manufacturer of genetic sequencing instruments and technologies. The contract is for preventative maintenance on two Illumina MiSeq machines, with a ceiling value of $16,376.44 and a performance period ending on September 13, 2024. Illumina is a for-profit manufacturer that has been awarded numerous federal contracts and grants to provide genomic sequencing platforms, reagents, and...
This firm fixed-price delivery order was awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $164,980.62 contract provides reagents to support whole genome sequencing using Illumina's MiSeq and NextSeq 2000 platforms, with a performance period through December 2023. The contract has no set-aside designation. Illumina is a well-established provider of sequencing solutions to federal agencies, having received...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $497,245.96, is for the provision of Illumina's genomic sequencing services and related products, including sequencing instruments like NextSeq, NovaSeq, and MiSeq systems, along with associated reagents, consumables, maintenance, and technical support. The contract does not...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 awarded a firm fixed price delivery order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $112,012.72 contract is for the repair and preventative maintenance of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems used by the agency. There was no set-aside for this award. Illumina has previously provided...
This is a $463,010.64 firm fixed price definitive contract awarded by the Veterans Integrated Service Network 17 (VISN 17) of the U.S. Department of Veterans Affairs (VA) to Illumina, Inc. The contract is for an ILLUMINA SERVICE CONTRACT to provide sequencing and array-based solutions to support genomic analysis and research. Illumina, a manufacturer of genetic and genomic analysis instruments and reagents, has previously provided products and services to federal agencies like the NIH, CDC,...
This is a firm fixed-price delivery order awarded by the Veterinary Services agency to Illumina, Inc., a leading provider of genetic sequencing technologies, for preventative maintenance of Illumina MiSeq machines. The contract has a ceiling value of $19,864.22 and a period of performance through November 22, 2024. Illumina has been awarded numerous federal contracts and grants, primarily focused on providing advanced genomic sequencing platforms, reagents, and related services to agencies...
This is a firm fixed-price purchase order worth $91,039.93 awarded by the Department of Veterans Affairs (VA) to Illumina, Inc. for a MiSeq System. The award has no set-aside designation. Illumina, a manufacturer of genetic sequencing and analysis instruments, has a history of providing sequencing systems and related products and services to federal agencies like the NIH, CDC, USDA, and VA. The MiSeq System is likely being acquired to support the VA's genomic sequencing and analysis needs....
This is a delivery order awarded to Illumina, Inc. under an Indefinite Delivery Indefinite Quantity (IDIQ) contract with the Department of Veterans Affairs (VA). The order is for the procurement of an Illumina MiSeq I100 Plus System, a next-generation DNA sequencing instrument. The contract is a firm fixed price award with a ceiling value of $89,678.40 and a period of performance through September 28, 2025. Illumina, a leading manufacturer of genomic analysis technologies, has been awarded...
This firm fixed-price purchase order contract was awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $150,974.70 contract is for a "MOLECULAR NEXT GENERATION SYSTEM" under an Other Transaction Authority (OT) agreement and does not have a set-aside designation. Illumina has previously received prime federal contracts and sub-grants from agencies like the National Institutes of Health, Centers...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract has a potential value of $13,956.00 and a completion date of December 13, 2025. Illumina has provided sequencing systems, reagents, and services to support genomic analysis for various federal agencies, including the VA, National Institutes of Health, and Department...